|

Haematopoietic growth factor Clinical Trials

1 actively recruiting trial across 1 location

Also known as: Filgrastim, G-CSF, Pegfilgrastim

Stanford, California1 trial

Brentuximab Vedotin in Early Stage Hodgkin Lymphoma

Stanford University - (Stanford Cancer Institute)

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.